Here's Why Omnicell (OMCL) Should Be in Your Portfolio Now
Wells Fargo Maintains Omnicell(OMCL.US) With Hold Rating, Maintains Target Price $26
Wells Fargo analyst Stan Berenshteyn maintains $Omnicell(OMCL.US)$ with a hold rating, and maintains the target price at $26.According to TipRanks data, the analyst has a success rate of 55.8% and a t
Omnicell (OMCL) Gains From New Offerings Amid Cost Woes
Estimating The Intrinsic Value Of Omnicell, Inc. (NASDAQ:OMCL)
Investors Aren't Buying Omnicell, Inc.'s (NASDAQ:OMCL) Revenues
With a price-to-sales (or "P/S") ratio of 1.3x Omnicell, Inc. (NASDAQ:OMCL) may be sending bullish signals at the moment, given that almost half of all the Medical Equipment companies in the United St
Analysts' Opinions Are Mixed on These Healthcare Stocks: Omnicell (OMCL), Tandem Diabetes Care (TNDM) and Amgen (AMGN)
Buy Rating on Omnicell Affirmed: Innovation and Growth Outlook Fuel Optimism for FY24 and Beyond
Piper Sandler Keeps Their Buy Rating on Omnicell (OMCL)
Omnicell | 10-Q: Quarterly report
Omnicell Supports Global Charity Mercy Ships With Pharmacy Technology Donation
Omnicell, Inc. (NASDAQ:OMCL) ("Omnicell" or the "Company"), a leader in transforming the pharmacy care delivery model, today announced continued support for the global charity Mercy Ships with the donation of solutions
Analysts Conflicted on These Healthcare Names: PROCEPT BioRobotics (PRCT), Springworks Therapeutics (SWTX) and Omnicell (OMCL)
Omnicell to Present at the BofA Securities 2024 Health Care Conference
Omnicell, Inc. (NASDAQ:OMCL), a leader in transforming the pharmacy care delivery model, will present at the BofA Securities 2024 Health Care Conference in Las Vegs, NV, on Wednesday, May 15, 2024 at 3:40 p.m.
Express News | Benchmark Reiterates Buy on Omnicell, Maintains $38 Price Target
Omnicell Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/03/2024 25.62% Benchmark → $38 Reiterates Buy → Buy 04/30/2024 25.62% Benchmark → $38 Reiterates Buy →
Analysts Offer Insights on Healthcare Companies: Day One Biopharmaceuticals (DAWN), Amgen (AMGN) and Omnicell (OMCL)
Barclays Sticks to Its Sell Rating for Omnicell (OMCL)
Earnings Call Summary | Omnicell(OMCL.US) Q1 2024 Earnings Conference
The following is a summary of the Omnicell, Inc. (OMCL) Q1 2024 Earnings Call Transcript:Financial Performance:Omnicell reported Q1 2024 total revenues of $246 million, a decrease from both the previo
Omnicell Shares Rise After Q1 Non-GAAP Earnings, Revenue Beat Estimates
Omnicell (OMCL) shares were up more than 3% in recent Thursday trading after the company's Q1 results beat analysts' expectations. The company reported Q1 non-GAAP earnings earlier Thursday of $0.03 p
Omnicell Inc (OMCL) Q1 2024 Earnings Analysis: Challenges Persist Amid Revenue Decline
GUIDANCE: (OMCL) OMNICELL Expects Fiscal Year 2024 EPS Range $0.90 - $1.40
07:40 AM EDT, 05/02/2024 (MT Newswires) -- GUIDANCE: (OMCL) OMNICELL Expects Fiscal Year 2024 EPS Range $0.90 - $1.40
No Data